» Articles » PMID: 10871328

Persistent Expression of 3-methylcholanthrene-inducible Cytochromes P4501A in Rat Hepatic and Extrahepatic Tissues

Overview
Specialty Pharmacology
Date 2000 Jun 28
PMID 10871328
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

We reported earlier that 3-methylcholanthrene (MC) persistently induces hepatic ethoxyresorufin O-deethylase activities (CYP1A1) in rats for up to 45 days. In this investigation, we tested the hypotheses that persistent expression of CYP1A1 activities is paralleled by sustained induction of CYP1A1/CYP1A2 apoproteins and their mRNAs and that this phenomenon is mediated by mechanisms other than retention of MC in the rat. Rats were given MC (93 micromol/kg) i.p., once daily for 4 days, and CYP1A1/1A2 parameters were measured in liver at selected time points. MC-elicited increases in CYP1A1/1A2 activities, apoprotein contents, and mRNA levels were sustained for several weeks after the last dose of MC treatment. MC also caused long-term induction of CYP1A1 in lungs and mammary glands. Rats treated with [(3)H]MC once daily for 4 days excreted 92. 3% of the administered radioactivity in feces and urine by day 15. The intrahepatic concentration of MC at the 15-day time point was 270 pmol/g. Dose-response studies showed that administration of MC (2 micromol/kg), which produced an intrahepatic concentration of 271 pmol/g after 24 h, did not induce CYP1A1/1A2 activities, strongly suggesting that the sustained induction of CYP1A1/1A2 was not due to retention of the parent MC in the body. Electrophoretic mobility shift assays revealed that persistent CYP1A1 induction by MC involved Ah receptor-independent mechanisms. In conclusion, our results support the hypothesis that persistent expression of CYP1A1/1A2 by MC is mediated by mechanisms independent of the retention of the parent carcinogen.

Citing Articles

Molecular mechanisms of pulmonary carcinogenesis by polycyclic aromatic hydrocarbons (PAHs): Implications for human lung cancer.

Stading R, Gastelum G, Chu C, Jiang W, Moorthy B Semin Cancer Biol. 2021; 76:3-16.

PMID: 34242741 PMC: 8728691. DOI: 10.1016/j.semcancer.2021.07.001.


Polycyclic Aromatic Hydrocarbon-induced Pulmonary Carcinogenesis in Cytochrome P450 (CYP)1A1- and 1A2-Null Mice: Roles of CYP1A1 and CYP1A2.

Gastelum G, Jiang W, Wang L, Zhou G, Borkar R, Putluri N Toxicol Sci. 2020; 177(2):347-361.

PMID: 32726451 PMC: 7818899. DOI: 10.1093/toxsci/kfaa107.


Polycyclic aromatic hydrocarbons: from metabolism to lung cancer.

Moorthy B, Chu C, Carlin D Toxicol Sci. 2015; 145(1):5-15.

PMID: 25911656 PMC: 4408964. DOI: 10.1093/toxsci/kfv040.


Polycyclic aromatic hydrocarbons and digestive tract cancers: a perspective.

Diggs D, Huderson A, Harris K, Myers J, Banks L, Rekhadevi P J Environ Sci Health C Environ Carcinog Ecotoxicol Rev. 2011; 29(4):324-57.

PMID: 22107166 PMC: 3247201. DOI: 10.1080/10590501.2011.629974.


Role of retinoic acid in the modulation of benzo(a)pyrene-DNA adducts in human hepatoma cells: implications for cancer prevention.

Zhou G, Richardson M, Fazili I, Wang J, Donnelly K, Wang F Toxicol Appl Pharmacol. 2010; 249(3):224-30.

PMID: 20888851 PMC: 3001276. DOI: 10.1016/j.taap.2010.09.019.